CN109409975A
|
|
Block chain merchandise storage device, block chain commodity storage system, recording device and block chain management system
|
CN106440400A
|
|
Solar smelting device and system
|
CN104650198A
|
|
Active peptides separated from Sphacelaria furcigera Kuetz capable of treating diabetes and application thereof
|
CN104402990A
|
|
Polypeptide for treating diabetes
|
CN105732803A
|
|
Aptamer NKXA6 specifically aiming at Neutrokine-alpha protein and application thereof
|
CN105732801A
|
|
Aptamer NKXA13 specifically aiming at Neutrokine-alpha protein and application thereof
|
CN105732800A
|
|
Aptamer NKXA15 specifically aiming at Neutrokine-alpha protein and application thereof
|
CN105732802A
|
|
Aptamer NKXA11 specifically aiming at Neutrokine-alpha protein and application thereof
|
CN104177488A
|
|
Specific nucleic acid aptamer for Neutrokine-alpha protein and application thereof
|
CN105732799A
|
|
Aptamer NKXA18 specifically aiming at Neutrokine-alpha protein and application thereof
|
CN105693846A
|
|
Aptamer NKXA10 specifically for Neutrokine-alpha protein and application of aptamer NKXA10
|
CN105693849A
|
|
Aptamer NKXA5 specifically for Neutrokine-alpha protein and application of aptamer NKXA5
|
CN105713083A
|
|
Specific aptamer NKXA17 for Neutrokine-alpha protein and application of specific aptamer NKXA17
|
CN105693847A
|
|
Aptamer NKXA9 specifically for Neutrokine-alpha protein and application of aptamer NKXA9
|
CN105693848A
|
|
Aptamer NKXA7 specifically for Neutrokine-alpha protein and application of aptamer NKXA7
|
CN105753967A
|
|
Nucleic acid aptamer NKXA14 specifically aiming at Neutrokine-alpha protein and application thereof
|
CN105732804A
|
|
Aptamer NKXA4 specifically aiming at Neutrokine-alpha protein and application thereof
|
CN104672305A
|
|
Anti-tumor peptide variant NC11 and application thereof
|
CN104610429A
|
|
Anti-tumor peptide variant NC13 and application thereof
|
CN104130311A
|
|
Antitumor peptide variant and application thereof
|